TY - JOUR
T1 - Natural products in the management of neurodegenerative diseases
AU - Goyal, Rajat
AU - Mittal, Pooja
AU - Gautam, Rupesh K.
AU - Kamal, Mohammad Amjad
AU - Perveen, Asma
AU - Garg, Vandana
AU - Alexiou, Athanasios
AU - Saboor, Muhammad
AU - Haque, Shafiul
AU - Farhana, Aisha
AU - Papadakis, Marios
AU - Ashraf, Ghulam Md
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Neurodegenerative diseases represent one of the utmost imperative well-being health issues and apprehensions due to their escalating incidence of mortality. Natural derivatives are more efficacious in various preclinical models of neurodegenerative illnesses. These natural compounds include phytoconstituents in herbs, vegetables, fruits, nuts, and marine and freshwater flora, with remarkable efficacy in mitigating neurodegeneration and enhancing cognitive abilities in preclinical models. According to the latest research, the therapeutic activity of natural substances can be increased by adding phytoconstituents in nanocarriers such as nanoparticles, nanogels, and nanostructured lipid carriers. They can enhance the stability and specificity of the bioactive compounds to a more considerable extent. Nanotechnology can also provide targeting, enhancing their specificity to the respective site of action. In light of these findings, this article discusses the biological and therapeutic potential of natural products and their bioactive derivatives to exert neuroprotective effects and some clinical studies assessing their translational potential to treat neurodegenerative disorders. Graphical Abstract: Common mechanisms, therapeutic targets, and molecular pathogenesis of neurodegeneration. It is focused on the biological and therapeutic potential of natural products and their bioactive derivatives to exert a neuroprotective effect on the pathologies of neurodegenerative diseases. (Figure presented.)
AB - Neurodegenerative diseases represent one of the utmost imperative well-being health issues and apprehensions due to their escalating incidence of mortality. Natural derivatives are more efficacious in various preclinical models of neurodegenerative illnesses. These natural compounds include phytoconstituents in herbs, vegetables, fruits, nuts, and marine and freshwater flora, with remarkable efficacy in mitigating neurodegeneration and enhancing cognitive abilities in preclinical models. According to the latest research, the therapeutic activity of natural substances can be increased by adding phytoconstituents in nanocarriers such as nanoparticles, nanogels, and nanostructured lipid carriers. They can enhance the stability and specificity of the bioactive compounds to a more considerable extent. Nanotechnology can also provide targeting, enhancing their specificity to the respective site of action. In light of these findings, this article discusses the biological and therapeutic potential of natural products and their bioactive derivatives to exert neuroprotective effects and some clinical studies assessing their translational potential to treat neurodegenerative disorders. Graphical Abstract: Common mechanisms, therapeutic targets, and molecular pathogenesis of neurodegeneration. It is focused on the biological and therapeutic potential of natural products and their bioactive derivatives to exert a neuroprotective effect on the pathologies of neurodegenerative diseases. (Figure presented.)
KW - Nanotechnology
KW - Natural products
KW - Neurodegenerative diseases
KW - Neuroinflammation
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=85193541008&partnerID=8YFLogxK
U2 - 10.1186/s12986-024-00800-4
DO - 10.1186/s12986-024-00800-4
M3 - Review article
AN - SCOPUS:85193541008
SN - 1743-7075
VL - 21
JO - Nutrition and Metabolism
JF - Nutrition and Metabolism
IS - 1
M1 - 26
ER -